Zoloth Laurie
San Francisco State University, CA, USA.
Am J Bioeth. 2002 Winter;2(1):3-11, 30. doi: 10.1162/152651602317267772.
This essay will address the ethical issues that have emerged in the first considerations of the newly emerging stem cell technology. Many of us in the field of bioethics were deliberating related issues as we first learned of the new science and confronted the ethical issues it raised. In this essay, I will draw on the work of colleagues who were asked to reflect on the early stages of the research (members of the IRBs, the Geron Ethicist Advisory Board, and the National Bioethics Advisory Commission) as the field debated the issues of consent, moral status, use of animal tissues, abortion, use of fetal tissue, and the nature and goals of entrepreneurial research. In this new capacity, ethicists weighed the problem of privacy, the role of justice considerations, and the issues of the marketplace in science. At this point, it is clear that far more issues remain unresolved than are settled, that there is largely unexplored territory ahead, and that the single most important task that faces us as a field is a steady call for ongoing conversation and public debate.
本文将探讨新兴干细胞技术首次进入人们视野时所引发的伦理问题。我们生物伦理学领域的许多人在初次了解这门新科学并面对其引发的伦理问题时,就一直在思考相关问题。在本文中,我将借鉴同事们的工作成果,他们应要求对研究的早期阶段进行了反思(包括机构审查委员会成员、杰龙伦理咨询委员会成员以及国家生物伦理咨询委员会成员),当时该领域正在就同意问题、道德地位、动物组织的使用、堕胎、胎儿组织的使用以及企业研究的性质和目标展开辩论。在这个新的背景下,伦理学家权衡了隐私问题、正义考量的作用以及科学领域中市场的问题。此时,显而易见的是,尚未解决的问题远比已解决的问题多得多,前方仍有大片未被探索的领域,而作为一个领域,我们面临的最重要任务是持续呼吁进行对话和公开辩论。